bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A J J M A M F J
2013: D N O S A

 
  Other news for:
Aspirin
Neoplasms
Ovarian Neoplasms
 Resources from HONselect
Daily Aspirin May Guard Against Ovarian Cancer
Study of almost 20,000 women found the drug lowered risk by 20 percent

By Robert Preidt

THURSDAY, Feb. 6, 2014 (HealthDay News) -- Taking aspirin every day might lower a woman's risk of developing ovarian cancer by one-fifth, a new study suggests.

Researchers from the U.S. National Cancer Institute analyzed data from 12 studies that involved nearly 8,000 women with ovarian cancer and close to 12,000 women without the disease to determine how the use of aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen (Tylenol) affected the risk of ovarian cancer.

About 18 percent of the women used aspirin regularly, 24 percent used non-aspirin NSAIDs (which include drugs such as ibuprofen and naproxen/Aleve) and 16 percent used acetaminophen. Those who used aspirin daily had a 20 percent lower risk of ovarian cancer than those who used aspirin less than once a week, the study found.

The risk of ovarian cancer was 10 percent lower in women who used non-aspirin NSAIDs at least once a week, compared to those who used them less often. However, this difference was not statistically significant, the researchers said.

There was no link between acetaminophen use and ovarian cancer risk, according to the study, which was published Feb. 6 in the Journal of the National Cancer Institute.

The findings add to the growing list of cancers and other diseases aspirin might help protect against, the researchers said. Although the study showed an association between aspirin use and a lower risk of ovarian cancer, it did not prove a cause-and-effect link.

"Our study suggests that aspirin regimens, proven to protect against heart attack, may reduce the risk of ovarian cancer as well," Britton Trabert, of the National Cancer Institute's division of cancer epidemiology, said in a U.S. National Institutes of Health news release.

"However intriguing our results are, they should not influence current clinical practice," Trabert said. "Additional studies are needed to explore the delicate balance of risk and benefit for this potential chemopreventive agent, as well as studies to identify [how] aspirin may reduce ovarian cancer risk."

Regular aspirin use can cause side effects such as bleeding in the digestive tract or hemorrhagic (bleeding) stroke, the study authors said. They also said people should get their doctor's approval before starting to take aspirin daily.

More than 20,000 women in the United States will be diagnosed with ovarian cancer this year, and more than 14,000 will die from the disease.

More information

The American Cancer Society has more about ovarian cancer.

SOURCE: U.S. National Institutes of Health, news release, Feb. 6, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=684648

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Ovarian Neoplasms
Aspirin
Risk
Women
Acetaminophen
Research Personnel
Specialty Chemicals and Products
Hemorrhage
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact